Reference no: EM133267927
Question - Assessing and Treating Vulnerable Populations for Depressive Disorders
-One vulnerable population to pick either children, adolescents, older adults, dementia patients, pregnant women or one not listed of your choice.
-Language appropriate for your audience (patient, caregiver, parent, etc.). Non-copyright images and/or information tables to make your patient medication guide interesting and appealing can be used.
1) Discuss Depressive disorder causes and symptoms
2) How depression is diagnosed for the vulnerable population of choice, why is this population considered vulnerable
3) Medication treatment options including risk vs benefits; side effects; FDA approvals for the vulnerable population of choice
4) Medication considerations of medication examples prescribed (see last bullet item)
5) What is important to monitor in terms of labs, comorbid medical issues with why important for monitoring
6) Special Considerations (must be specific, not general and address at least one for EACH category; must demonstrate critical thinking beyond basics of HIPPA and informed consent!): legal considerations, ethical considerations, cultural considerations, social determinants of health
7) Where to follow up in your local community for further information
8) Provide 3 examples of how to write a proper prescription that would provide to the patient or transmit to the pharmacy.